Checkpoint inhibitors for stage I to III non‐small cell lung cancer treated with surgery or radiotherapy with curative intent: a generic protocol

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the effectiveness and safety of immune checkpoint inhibitors in people with stage I to III NSCLC who receive surgery or radiotherapy with curative intent.

Na minha lista:
Detalhes bibliográficos
Publicado no:Cochrane Database Syst Rev
Main Authors: Zhu, Zhen, Zhang, Kexun, Cai, Ning, Charbek, Edward, Miller, Aaron C, Zhu, Sibo, Suo, Chen, Chen, Xingdong, Song, Huan
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd 2019
Assuntos:
Medicine General & Introductory Medical Sciences
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6592372/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD013364
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados